<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Headache Pain</journal-id><journal-id journal-id-type="iso-abbrev">J Headache Pain</journal-id><journal-title-group><journal-title>The Journal of Headache and Pain</journal-title></journal-title-group><issn pub-type="ppub">1129-2369</issn><issn pub-type="epub">1129-2377</issn><publisher><publisher-name>Springer Milan</publisher-name><publisher-loc>Milan</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31924166</article-id><article-id pub-id-type="pmc">6954535</article-id><article-id pub-id-type="publisher-id">1074</article-id><article-id pub-id-type="doi">10.1186/s10194-020-1074-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The epidemiology of headaches among patients with epilepsy: a systematic review and meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4419-0016</contrib-id><name><surname>Duko</surname><given-names>Bereket</given-names></name><address><email>berkole.dad@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Ayalew</surname><given-names>Mohammed</given-names></name><address><email>mameayale@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Toma</surname><given-names>Alemayehu</given-names></name><address><email>alemayehutoma@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8953 2273</institution-id><institution-id institution-id-type="GRID">grid.192268.6</institution-id><institution>College of Medicine and Health Sciences, </institution><institution>Hawassa University, </institution></institution-wrap>Hawassa, Ethiopia </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>21</volume><issue>1</issue><elocation-id>3</elocation-id><history><date date-type="received"><day>9</day><month>12</month><year>2019</year></date><date date-type="accepted"><day>5</day><month>1</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Headache is the symptom of pain in the face, head or neck that causes disability in most people with medical and neurological disorders. It frequently co-occurs with most chronic diseases such as epilepsy and significantly impacts the quality of life. However, epidemiologic data from different studies showed different rates of prevalence. Therefore, we conducted this review to summarize the available epidemiologic evidence on the topic and formulate recommendations for future research and clinical practice.</p></sec><sec><title>Methods</title><p id="Par2">We followed the preferred reporting items for systematic review and meta-analysis (PRISMA) guidelines. We systematically searched the literature using popular databases such as PubMed, EMBASE, Psych-INFO, and SCOPUS. We further scanned the reference lists of the eligible studies to supplement our electronic search. The Comprehensive Meta-Analysis software version 3.0 (CMA 3.0) was used to conduct a meta-analysis. Subgroup and sensitivity analysis were performed and Cochran&#x02019;s Q- and the I<sup>2</sup>- test were used to assess the source of heterogeneity. The funnel plot and Egger&#x02019;s regression tests were used to assess potential publication bias.</p></sec><sec><title>Results</title><p id="Par3">A total of 17 studies conducted both in developed and developing countries including 5564 study participants were combined in this meta-analysis. The pooled estimated prevalence of headache among patients with epilepsy was 48.4%. The pooled estimated prevalence of Inter-Ictal headache (IIH) (42.2%) and Postictal headache (PIH) (43.1%) were higher when compared to tension-type headache (TTH) (26.2%), migraine with aura (26.0%) and migraine without aura (10.4%). The pooled prevalence of headache was 50.6% and 49.5% for developed and developing countries respectively. The pooled prevalence of headache among patients with epilepsy was considerably higher among females (63.0%) when compared to males (33.3%). Moreover, the pooled estimated prevalence of headache among patients with epilepsy was ranging from 46.0% to 52.2% in a leave-one-out sensitivity analysis.</p></sec><sec><title>Conclusion</title><p id="Par4">The pooled estimated prevalence of headache among patients with epilepsy was considerably high (48.4%). Screening and appropriate management of headaches among patients with epilepsy are warranted.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Prevalence</kwd><kwd>Headaches</kwd><kwd>Epilepsy</kwd><kwd>Seizure</kwd><kwd>Systematic review</kwd><kwd>Meta-analysis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par15">Neurological disorders are emerging challenges to health care systems and requiring further study, government as well as social engagement, and improvements in health care infrastructure [<xref ref-type="bibr" rid="CR1">1</xref>]. Epilepsy is one of the neurologic disorders which is characterized by repeated seizure attacks which result from paroxysmal uncontrolled discharges of neurons [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>]. The World Health Organization defines epilepsy as having two or more unprovoked seizures [<xref ref-type="bibr" rid="CR2">2</xref>].</p><p id="Par16">Epilepsy affected around 50 million people worldwide in 2019 [<xref ref-type="bibr" rid="CR2">2</xref>]. Of these, 80% of people with epilepsy live in low- and middle-income countries [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. A systematic review and meta-analysis conducted in 2017 reported that the point prevalence of active epilepsy was 6.38 per 1000 persons while the lifetime prevalence was 7.60 per 1000 persons [<xref ref-type="bibr" rid="CR8">8</xref>]. Further, the annual cumulative incidence of epilepsy was 67.77 per 100,000 persons while the incidence rate was 61.44 per 100,000 person-years [<xref ref-type="bibr" rid="CR8">8</xref>]. Finding from another study also revealed that the lifetime incidence of epilepsy is ranging from 1 to 26 with a peak age ranges from 30 to 50&#x02009;years [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par17">Headache is the symptom of pain in the face, head, or neck that causes disability in most people with medical and neurological disorders [<xref ref-type="bibr" rid="CR10">10</xref>]. There are different types of headaches that can occur in individuals but generally can be classified as primary and secondary headaches [<xref ref-type="bibr" rid="CR11">11</xref>]. Primary headaches broadly include migraines and tension-type headaches [<xref ref-type="bibr" rid="CR12">12</xref>]. Migraines are characterized by pulsing head pain, nausea, and sensitivity to light and sound whereas tension-type headaches present with non-pulsing &#x0201c;band-like&#x0201d; pressure on both sides of the head but not accompanied by other symptoms [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par18">Headache frequently co-morbid with most chronic diseases such as epilepsy [<xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR17">17</xref>]. For instance, a review conducted to see the relationship between headache and epilepsy reported the comorbidity of headache and epilepsy as a result of common genetic mutations and clinical features [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>], but the suggested link is not revealed conclusive evidence of a real causal association [<xref ref-type="bibr" rid="CR20">20</xref>]. Further, studies also suggested that there are genetic relationships [<xref ref-type="bibr" rid="CR19">19</xref>] as well as common underlying pathophysiological mechanisms including the imbalance between excitatory and inhibitory neurotransmitters in epilepsy and headache, especially for migraine [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Proposed theories for shared etiologies include ion channel dysfunction, glutamatergic mechanisms, and mitochondrial dysfunction [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. These suggest that the cause of headache and epilepsy are multifactorial and hence need different diagnostic and interventional approaches [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par19">Epidemiologic evidence from different studies reported different rates of prevalence of headache among epileptic patients [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. For example, a cross-sectional study conducted in China to assess the prevalence of headache among patients with epilepsy reported 60.1% [<xref ref-type="bibr" rid="CR25">25</xref>]. In contrast, a study assessed the prevalence of headache among epileptic patients in Japan revealed 23% [<xref ref-type="bibr" rid="CR26">26</xref>]. Thus, estimating the burden of headaches among patients with epilepsy is critically important. Even though a systematic review and meta-analysis has been conducted in 2017 on a similar area of study [<xref ref-type="bibr" rid="CR27">27</xref>], however, it only assessed the comorbid relationship between migraine and epilepsy [<xref ref-type="bibr" rid="CR21">21</xref>]. In spite of that, the current review tried to investigate the pooled prevalence of headaches such as migraine, tension-type headaches, and others among patients with epilepsy to summarize the available epidemiologic evidence on the topic and formulate recommendations for future research as well as clinical practice.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study design and search process</title><p id="Par20">This systematic review and meta-analysis followed the preferred reporting items for systematic review and meta-analysis (PRISMA) guidelines [<xref ref-type="bibr" rid="CR28">28</xref>]. We reviewed research articles that assessed the prevalence of headaches among patients with epilepsy. We systematically searched the literature using common databases such as PubMed, EMBASE, Psych-INFO, and SCOPUS. Medical Subject Headings (MESH) terms were used to perform the electronic database search in PubMed: <italic>&#x0201c;(headache OR migraine OR tension-type headache OR Headache on seizure-day OR postictal headache OR ictal headache OR primary headaches OR cluster headaches) AND (prevalence OR magnitude OR epidemiology OR incidence)) AND (Epilepsy OR Seizure disorder OR convulsion OR seizure attack OR paroxysm)&#x0201d;.</italic> The EMBASE, Psych-INFO, and SCOPUS databases were also comprehensively searched by applying the search terms used in PubMed for each database accordingly. Further, we also boosted our literature search through a manual search of the reference lists of eligible articles.</p></sec><sec id="Sec4"><title>Eligibility criteria</title><p id="Par21">Studies were included in the review if they fulfill the following inclusion criteria: observational studies including cross-sectional design; conducted among patients with epilepsy or seizure disorders, studies that were published in the English language and determined the prevalence of primary headaches among patients with epilepsy. However, we excluded commentaries, letters, duplicate studies, editorials, reviews, and short communications as they did not satisfy the eligibility criteria.</p></sec><sec id="Sec5"><title>Methods for data extraction and quality assessment</title><p id="Par22">The data extraction from the relevant studies was employed by two independent reviewers. We extracted the following information from each study: the name of the first author, the year of publication, study setting, and design, sample size, prevalence, and tools used to estimate the magnitude of AUD, type of headaches reported and the reported magnitude by gender of the participants. Disagreements raised during data extraction were solved by discussion. The Newcastle-Ottawa Scale (NOS) was used to check the quality of the included studies in the meta-analysis [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. The data measurement tools used to assess types of headaches, sample size, methodological quality, types of headache, sample representativeness and comparability between participants were the domains of the NOS scale to assess the quality of the included studies.</p></sec><sec id="Sec6"><title>Definition of terms</title><p id="Par23">Headache is the symptom of pain in the face, head, or neck that causes disability in most people with medical and neurological disorders [<xref ref-type="bibr" rid="CR10">10</xref>]. In this review, headache was considered when the studies investigated and reported the prevalence of primary headaches such as migraine (with or without aura), tension-type headache, Ictal headache, and post-ictal headache among patients with epilepsy based on any standardized and validated screening instruments used to assess headaches such as Migraine Screening &#x02013;Questionnaire (MSQ), the International Classification of Headache Disorders 2nd or 3rd edition (ICHD-2, 3), the Headache-Attributed Lost Time (HALT) and the six-item Headache Impact Test.</p></sec><sec id="Sec7"><title>Data synthesis and analysis</title><p id="Par24">A meta-analysis was conducted by a Comprehensive Meta-Analysis software version 3.0 (CMA-3.0). The random-effect model for meta-analysis was employed to pool the overall prevalence of primary headaches among patients with epilepsy. The magnitude of statistical heterogeneity between the eligible articles was checked by Q-statistic and the I<sup>2</sup>-statistics [<xref ref-type="bibr" rid="CR31">31</xref>] and values of 25, 50 and 75% were used to represent low, medium and high quality respectively [<xref ref-type="bibr" rid="CR32">32</xref>]. Further, we also conducted a subgroup and sensitivity analysis to check potential source bias among the included studies. The types of primary headaches assessed, the country study conducted, and study design and the gender of study participants (male or female) were used as a moderator to assess subgroup and sensitivity analysis. The funnel plot and Egger&#x02019;s regression tests were used to assess potential publication bias [<xref ref-type="bibr" rid="CR33">33</xref>].</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Identification of studies</title><p id="Par25">The electronic database along with additional manual reference searches resulted in a total of 3295 research articles. Of these, 104 articles were retrieved for further screening and 87 articles were excluded, 17 research articles were included in the final meta-analysis (see Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).
<fig id="Fig1"><label>Fig. 1</label><caption><p>PRISMA flowchart of review search</p></caption><graphic xlink:href="10194_2020_1074_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec10"><title>Characteristics of included studies</title><p id="Par26">A total of seventeen studies conducted both in developed and developing countries including 5564 study participants were included in this meta-analysis. The studies included in this systematic review were published between 2004 and 2019 and the sample size ranging between 86 in Turkey and 1109 in China. Of 17 studies included the final meta-analysis, one from the USA [<xref ref-type="bibr" rid="CR34">34</xref>], one from India [<xref ref-type="bibr" rid="CR35">35</xref>], three from Iran [<xref ref-type="bibr" rid="CR36">36</xref>&#x02013;<xref ref-type="bibr" rid="CR38">38</xref>], one from Japan [<xref ref-type="bibr" rid="CR26">26</xref>], one from Taiwan [<xref ref-type="bibr" rid="CR35">35</xref>], one from Italy [<xref ref-type="bibr" rid="CR36">36</xref>], three from China [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>], one from Turkey [<xref ref-type="bibr" rid="CR41">41</xref>], one from Lithuania [<xref ref-type="bibr" rid="CR42">42</xref>], one from Montenegro [<xref ref-type="bibr" rid="CR43">43</xref>], one from Bangladesh [<xref ref-type="bibr" rid="CR44">44</xref>] and two from Egypt [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Regarding types of headaches assessed among patients with epilepsy, nine studies assessed tension-type headache, fifteen studies assessed migraine with aura, three studies assessed migraine without aura, and seven studies assessed both Ictal headache (IH) and Postictal headache (PIH). The studies included in the review used Migraine Screening &#x02013;Questionnaire (MSQ), the International Classification of Headache Disorders 2nd and 3rd edition (ICHD-2, 3), the Headache-Attributed Lost Time (HALT) and the six-item Headache Impact Test (HIT-6) to assess primary headaches among patients with epilepsy (See Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristics of the included studies on prevalence of headache among patients with epilepsy</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">First author, date</th><th rowspan="2">Country</th><th rowspan="2">Sample size</th><th rowspan="2">Study design</th><th rowspan="2">Data collection tool</th><th colspan="2">Prevalence (%)</th><th rowspan="2">Prevalence of any headache (%)</th><th colspan="5">Prevalence (%)</th></tr><tr><th>Male</th><th>Female</th><th>MA</th><th>MOA</th><th>TTH</th><th>IIH</th><th>PIH</th></tr></thead><tbody><tr><td>Erin K, 2017 [<xref ref-type="bibr" rid="CR34">34</xref>]</td><td>USA</td><td>160</td><td>Cross-sectional</td><td>Self-report</td><td>NA</td><td>NA</td><td>40.00</td><td>NA</td><td/><td/><td/><td/></tr><tr><td>Singla et al., 2019 [<xref ref-type="bibr" rid="CR35">35</xref>]</td><td>India</td><td>123</td><td>Cohort</td><td>Self-report</td><td>NA</td><td>NA</td><td>47.10</td><td>21.10</td><td/><td>26.00</td><td/><td/></tr><tr><td>Sayena J et al., 2015 [<xref ref-type="bibr" rid="CR36">36</xref>]</td><td>Iran</td><td>150</td><td>Cross-sectional</td><td>MSQ</td><td>NA</td><td>NA</td><td>32.60</td><td>15.30</td><td>17.30</td><td/><td/><td/></tr><tr><td>Ashjazadeh N, 2015 [<xref ref-type="bibr" rid="CR37">37</xref>]</td><td>Iran</td><td>100</td><td>Cross-sectional</td><td>ICHD-II</td><td>48</td><td>52</td><td>54.00</td><td>15.00</td><td/><td>39.00</td><td>42.53</td><td>31.48</td></tr><tr><td>Fattahzadeh AG et al., 2017 [<xref ref-type="bibr" rid="CR38">38</xref>]</td><td>Iran</td><td>900</td><td>Cross-sectional</td><td>HIS</td><td>NA</td><td>NA</td><td>85.20</td><td>27.90</td><td/><td>48.20</td><td/><td/></tr><tr><td>Ito M et al., 2004 [<xref ref-type="bibr" rid="CR26">26</xref>]</td><td>Japan</td><td>364</td><td>Cross-sectional</td><td>ICHD-III</td><td>NA</td><td>NA</td><td>40.40</td><td>26.00</td><td/><td/><td>50.00</td><td>40.40</td></tr><tr><td>Inn-Chi L., 2018 [<xref ref-type="bibr" rid="CR47">47</xref>]</td><td>Taiwan</td><td>476</td><td>Cross-sectional</td><td>ICHD-III</td><td>NA</td><td>NA</td><td>9.70</td><td>9.70</td><td/><td/><td/><td/></tr><tr><td>Mainieri et al., 2015 [<xref ref-type="bibr" rid="CR39">39</xref>]</td><td>Italy</td><td>388</td><td>Cross-sectional</td><td>ICHD-II</td><td>NA</td><td>NA</td><td>53.90</td><td>26.30</td><td/><td>19.10</td><td>48.50</td><td>19.10</td></tr><tr><td>Zhang et al., 2018 [<xref ref-type="bibr" rid="CR37">37</xref>]</td><td>China</td><td>339</td><td>Cross-sectional</td><td>ICHD-III</td><td>17</td><td>29</td><td>23.00</td><td>23.00</td><td/><td/><td/><td/></tr><tr><td>G&#x000f6;khan &#x000d6; et al., 2010 [<xref ref-type="bibr" rid="CR41">41</xref>]</td><td>Turkey</td><td>86</td><td>Cohort</td><td>Self-report</td><td>NA</td><td>NA</td><td>47.60</td><td>13.90</td><td>12.80</td><td>16.30</td><td/><td/></tr><tr><td>Mameni&#x00161;kiene R et al., 2016 [<xref ref-type="bibr" rid="CR42">42</xref>]</td><td>Lithuania</td><td>289</td><td>Cross-sectional</td><td>HALT</td><td>42</td><td>62</td><td>83.20</td><td>31.70</td><td/><td>39.00</td><td>77.90</td><td/></tr><tr><td>Wang et al., 2014 [<xref ref-type="bibr" rid="CR25">25</xref>]</td><td>China</td><td>1109</td><td>Cross-sectional</td><td>ICHD-II</td><td>57</td><td>64</td><td>60.10</td><td>60.20</td><td/><td>30.30</td><td>11.70</td><td>34.10</td></tr><tr><td>Slavica V. et al., 2012 [<xref ref-type="bibr" rid="CR43">43</xref>]</td><td>Montenegro</td><td>259</td><td>Cross-sectional</td><td>ICDH II</td><td>20</td><td>85</td><td>48.00</td><td>15.44</td><td/><td/><td/><td>28.00</td></tr><tr><td>Shamim R..,2018 [<xref ref-type="bibr" rid="CR44">44</xref>]</td><td>Bangladesh</td><td>376</td><td>Cross-sectional</td><td>NA</td><td>NA</td><td>NA</td><td>80.60</td><td>NA</td><td/><td/><td/><td>80.60</td></tr><tr><td>Kwan P et al., 2008 [<xref ref-type="bibr" rid="CR38">38</xref>]</td><td>China</td><td>227</td><td>Cohort</td><td>HIT-6</td><td>68</td><td>NA</td><td>22.00</td><td>4.80</td><td>3.10</td><td>7.00</td><td>19.80</td><td/></tr><tr><td>Yosria AHA. et al., 2017 [<xref ref-type="bibr" rid="CR41">41</xref>]</td><td>Egypt</td><td>118</td><td>Case control</td><td>ICHD-III</td><td>31</td><td>69</td><td>24.60</td><td>79.30</td><td/><td/><td/><td/></tr><tr><td>Sayed MA et al<italic>, 2019</italic> [<xref ref-type="bibr" rid="CR42">42</xref>]</td><td>Egypt</td><td>100</td><td>Cross-sectional</td><td>ICHD-III</td><td>27</td><td>73</td><td>78.00</td><td>70.60</td><td/><td>25.58</td><td>50.00</td><td>66.50</td></tr></tbody></table><table-wrap-foot><p>Foot notes: <italic>MSQ</italic> Migraine Screening Questionnaire, <italic>ICHD-II</italic> The International Classification of Headache Disorders 2nd edition, <italic>ICHD-3</italic> The International Classification of Headache Disorders 3rd edition, <italic>HALT</italic> The Headache-Attributed Lost Time, <italic>HIT-6</italic> The six-item Headache Impact Test, <italic>IHS</italic> International Headache Society, <italic>MA</italic> migraine with aura, <italic>MOA</italic> Migraine without aura, <italic>TTH</italic> Tension type headache, <italic>PIH</italic> Post ictal headache, <italic>IIH</italic> Inter Ictal headache</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec11"><title>Quality of included studies</title><p id="Par27">The Newcastle Ottawa Scale (NOS) was used to check the quality of the included studies. Of 17 studies included in the review, 14 studies were of high quality (NOS score&#x02009;&#x0003e;&#x02009;8), 2 studies were moderate quality (NOS score between 6 and 7) and 1 study was low-quality studies (NOS score&#x02009;&#x0003c;&#x02009;5) (See Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>).</p></sec><sec id="Sec12"><title>The prevalence of headaches among patients living with epilepsy (meta-analysis)</title><p id="Par28">The pooled prevalence estimate of headache among patients with epilepsy was 48.4% (95% CI; 36.6&#x02013;61.2). We found an apparent heterogeneity among included studies in this meta-analysis (<italic>I</italic><sup><italic>2</italic></sup>&#x000a0;=&#x02009;98.458%; <italic>p</italic>&#x000a0;&#x0003c;&#x02009;&#x000a0;0.001) (See Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).
<fig id="Fig2"><label>Fig. 2</label><caption><p>The prevalence of headache among patients with Epilepsy: a meta-analysis (forest plot)</p></caption><graphic xlink:href="10194_2020_1074_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec13"><title>Subgroup and sensitive analysis</title><p id="Par29">The available epidemiologic evidence was diverse by the types of headaches present in patients with epilepsy, the country in which a study conducted, the methodological design and the gender of study participants (male or female).</p><p id="Par30">The pooled prevalence of headaches among patients with epilepsy differed when types of headaches differ. Thus, the pooled prevalence of Inter Ictal headache (IIH) (42.2%) and Postictal headache (PIH) (43.1%) among patients with epilepsy were higher when compared to tension-type headache (TTH) (26.2%) (See Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>), migraine with aura (26.0%) (See Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>) and migraine without aura (10.4%).
<fig id="Fig3"><label>Fig. 3</label><caption><p>The prevalence of tension-type-headache among patients with epilepsy: a meta-analylsis (forest Plot)</p></caption><graphic xlink:href="10194_2020_1074_Fig3_HTML" id="MO3"/></fig>
<fig id="Fig4"><label>Fig. 4</label><caption><p>The prevalence of migraine-with-aura among patients with epilepsy: a meta-analysis&#x000a0;(forest plot)</p></caption><graphic xlink:href="10194_2020_1074_Fig4_HTML" id="MO4"/></fig></p><p id="Par31">The pooled prevalence of primary headaches among patients living with epilepsy did not differ in the subgroup analysis of developing and developed countries as a moderator. For example, the pooled prevalence of headaches was 50.6% (95%CI 35.9&#x02013;65.3) and 49.5% (95%CI 38.1&#x02013;60.9) for developed and developing countries respectively. The variation between the studies was statistically significant (<italic>P</italic>&#x000a0;&#x0003c;&#x02009;&#x000a0;0.001).</p><p id="Par32">We also performed a subgroup analysis using the methodological design studies conducted as a moderator. The prevalence of primary headaches was higher in the studies that used a cross-sectional study design (53.4%) when compared to the studies that used cohort (37.9%) and case-control study (25.0%) designs.</p><p id="Par33">We further conducted a subgroup analysis using the gender of the study participants as a moderator. The pooled prevalence of headaches among patients with epilepsy was considerably higher among females (63.0%) when compared to males (33.3%). The heterogeneity was significant for both studies that assessed the prevalence of headaches in females (<italic>I</italic><sup>2</sup>&#x000a0;=&#x02009;96.958%, <italic>p</italic>&#x000a0;&#x0003c;&#x02009;&#x000a0;0.001) and (<italic>I</italic><sup><italic>2</italic></sup>&#x000a0;=&#x02009;97.451%, <italic>p</italic>&#x02009;&#x0003c;&#x02009;&#x000a0;0.001) (See Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Subgroup and sensitivity analysis for the prevalence of headaches among patients with epilepsy</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Subgroups</th><th rowspan="2">No. of studies</th><th rowspan="2">Prevalence (%)</th><th rowspan="2">95% CI</th><th colspan="3">Heterogeneity within the study (I<sup>2</sup>, Q and <italic>p</italic>-value)</th></tr><tr><th>Q-value</th><th>I<sup>2</sup> (%)</th><th><italic>P</italic>-value</th></tr></thead><tbody><tr><td colspan="7">Types of Headache</td></tr><tr><td>&#x02003;Tension type headache (TTH)</td><td>9</td><td>26.2</td><td>18.9&#x02013;35.0</td><td>197.938</td><td>95.958</td><td rowspan="5">&#x0003c;&#x02009; 0.01</td></tr><tr><td>&#x02003;Migraine with aura</td><td>15</td><td>26.0</td><td>17.5&#x02013;36.7</td><td>738.659</td><td>98.105</td></tr><tr><td>&#x02003;Migraine without aura</td><td>3</td><td>10.4</td><td>5.20&#x02013;19.7</td><td>11.064</td><td>81.924</td></tr><tr><td>&#x02003;Ictal headache (IH)</td><td>7</td><td>42.2</td><td>26.8&#x02013;59.2</td><td>523.957</td><td>98.664</td></tr><tr><td>&#x02003;Post ictal headache (PIH)</td><td>7</td><td>43.1</td><td>30.9&#x02013;56.3</td><td>348.352</td><td>97.991</td></tr><tr><td colspan="7">Countries</td></tr><tr><td>&#x02003;Developed</td><td>6</td><td>50.6</td><td>35.9&#x02013;65.3</td><td>142.400</td><td>96.489</td><td rowspan="2">&#x0003c;&#x02009; 0.01</td></tr><tr><td>&#x02003;Developing</td><td>11</td><td>49.5</td><td>38.1&#x02013;60.9</td><td>885.368</td><td>98.871</td></tr><tr><td colspan="7">Study design</td></tr><tr><td>&#x02003;Cross-sectional</td><td>13</td><td>53.4</td><td>39.2&#x02013;67.0</td><td>909.646</td><td>98.681</td><td rowspan="3">&#x0003c;&#x02009; 0.01</td></tr><tr><td>&#x02003;Cohort</td><td>3</td><td>37.9</td><td>21.3&#x02013;57.8</td><td>30.119</td><td>93.360</td></tr><tr><td>&#x02003;Case-control</td><td>1</td><td>25.0</td><td>18.0&#x02013;33.6</td><td>0.000</td><td>0.000</td></tr><tr><td colspan="7">Gender</td></tr><tr><td>&#x02003;Male</td><td>7</td><td>33.3</td><td>21.1&#x02013;48.3</td><td>235.349</td><td>97.451</td><td rowspan="2">&#x0003c;&#x02009; 0.01</td></tr><tr><td>&#x02003;Female</td><td>7</td><td>63.0</td><td>49.1&#x02013;75.1</td><td>197.232</td><td>96.958</td></tr></tbody></table></table-wrap></p><p id="Par34">Moreover, we conducted a leave-one-out sensitivity analysis to further explore the source heterogeneity. The pooled prevalence of headaches among patients with epilepsy was ranging from 46.0% (35.0&#x02013;57.4) to 52.2% (40.8&#x02013;63.4) in the leave-one-out sensitivity analysis (See Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>).
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Leave-one-out-sensitivity analysis of prevalence of headache among patients: prevalence and 95% confidence</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Study excluded</th><th>Prevalence (%)</th><th>95%CI</th></tr></thead><tbody><tr><td>Singla et al., 2019</td><td>48.9</td><td>36.2&#x02013;61.8</td></tr><tr><td>Erin K, 2017</td><td>49.4</td><td>36.6&#x02013;62.3</td></tr><tr><td>Sayena J et al., 2015</td><td>49.9</td><td>37.2&#x02013;62.6</td></tr><tr><td>Ito M et al., 2004</td><td>49.4</td><td>36.4&#x02013;62.5</td></tr><tr><td>Inn-Chi L., 2018</td><td>52.2</td><td>40.8&#x02013;63.4</td></tr><tr><td>Mainieri et al., 2015</td><td>48.5</td><td>35.3&#x02013;61.9</td></tr><tr><td>Zhang et al., 2018</td><td>50.7</td><td>38.3&#x02013;62.9</td></tr><tr><td>G&#x000f6;khan &#x000d6; et al., 2010</td><td>48.9</td><td>36.2&#x02013;61.7</td></tr><tr><td>Ashjazadeh N, 2015</td><td>48.5</td><td>35.8&#x02013;61.4</td></tr><tr><td>Mameni&#x00161;kiene R et al., 2016</td><td>46.3</td><td>34.2&#x02013;58.9</td></tr><tr><td>Wang et al., 2014</td><td>48.1</td><td>34.2&#x02013;62.4</td></tr><tr><td>Slavica V. et al., 2012</td><td>48.9</td><td>35.9&#x02013;62.0</td></tr><tr><td>Shamim R..,2018</td><td>46.5</td><td>34&#x02013;3-59.1</td></tr><tr><td>P. Kwan et al., 2008</td><td>50.7</td><td>38.3&#x02013;63.1</td></tr><tr><td>Yosria AHA. et al., 2017</td><td>50.4</td><td>37.9&#x02013;63.0</td></tr><tr><td>Sayed MA et al., 2019</td><td>46.9</td><td>34.5&#x02013;59.6</td></tr><tr><td>Fattahzadeh AG et al., 2017</td><td>46.0</td><td>35.0&#x02013;57.4</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec14"><title>Publication bias</title><p id="Par35">For the overall meta-analysis of the prevalence of headache among patients with epilepsy, both funnel plot and Egger&#x02019;s regression tests revealed no evidence of potential publication bias (B&#x02009;=&#x02009;-6.59, SE&#x02009;=&#x02009;5.23, <italic>P</italic>&#x000a0;=&#x02009;0.23) (See Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>).
<fig id="Fig5"><label>Fig. 5</label><caption><p>Funnel plot showing no publication bias among studies included in the review</p></caption><graphic xlink:href="10194_2020_1074_Fig5_HTML" id="MO5"/></fig></p></sec></sec><sec id="Sec15"><title>Discussion</title><p id="Par36">To our knowledge, this is the first systematic review and meta-analysis that assessed the prevalence of headaches among patients with epilepsy globally. In this review, the pooled prevalence of headaches among patients with epilepsy was 48.4%. The available epidemiologic evidence was diverse by the types of headaches present in patients with epilepsy, the country in which a study conducted, the methodological design and the gender of study participants (male or female). Further, the majority of included studies were of high methodological quality.</p><p id="Par37">The pooled prevalence estimate of headache among patients with epilepsy in the current systematic review and meta-analysis (48.4%) was in line with the World Health Organization (WHO) report of 2016 which estimated the prevalence of headache disorders among adults was 50% [<xref ref-type="bibr" rid="CR48">48</xref>]. However, the pooled prevalence of headache among patients with epilepsy was higher than the reported prevalence of headache in the general population. For example, the studies conducted to assess the prevalence of primary headache disorders in a geriatric population (age&#x02009;&#x0003e;&#x02009;60&#x02009;years) in a rural area of Northern China reported 10.3% [<xref ref-type="bibr" rid="CR49">49</xref>]. This study finding was supported by a community-based cross-sectional study conducted to assess the burden of primary headache disorders among Kuwaiti children and adolescents and revealed 19.4% [<xref ref-type="bibr" rid="CR50">50</xref>]. The finding from a study conducted to assess the prevalence of headache among medical students in Saudi Arabia also reported of 41.66% [<xref ref-type="bibr" rid="CR51">51</xref>]. Further, a study that described the clinical characteristics of primary headaches occurring in a group of HIV-infected individuals and reported 38% [<xref ref-type="bibr" rid="CR52">52</xref>]. The discrepancy in the prevalence of headache may be due to the difference in the study population, setting and, also primary headaches such as migraines share some common signs and symptoms with epilepsy, therefore, this may increase the prevalence of headaches among patients with epilepsy. In addition, there are numerous ways in which common genetic factors such as SCN1A mutations that predispose persons to the development of headaches and epilepsy [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR53">53</xref>] and the corresponding mutations may result in higher prevalence of headaches among patients with epilepsy [<xref ref-type="bibr" rid="CR54">54</xref>]. A study conducted to assess the contribution of a shared genetic susceptibility to migraine and epilepsy reported that the prevalence of a history of migraine was significantly increased in participants with affected first degree relatives [<xref ref-type="bibr" rid="CR55">55</xref>]. Further, shared environmental factors e.g. head injury, may result in brain hyper-excitability [<xref ref-type="bibr" rid="CR56">56</xref>], and these may play a great role in the variation of prevalence of headache among patients with epilepsy when compared to the general population.</p><p id="Par38">In this review, the pooled prevalence of migraine and tension-type headache in patients with epilepsy was 26.0% and 26.2% respectively. The pooled estimated prevalence of migraine and tension-type headaches were higher than pre-Ictal headaches reported by different studies [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Further, the pooled prevalence of migraine was higher than the prevalence of migraine and tension-type headache in the general population. For example, a research article published simultaneously by Cephalalgia Headache and the Journal of Headache and Pain in 2013 showed that the global prevalence of migraine in the general population was 14.7% [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. Also, a systematic review conducted in 2010 to assess the prevalence of chronic migraines reported 0&#x02013;5.1% in the general population [<xref ref-type="bibr" rid="CR59">59</xref>]. This may be due to the comorbidity of migraine and epilepsy in which the two disorders experience common symptoms, risk factors, and drug therapy [<xref ref-type="bibr" rid="CR25">25</xref>]. Findings from previous studies support the hypothesis of cortical excitability as a plausible mechanism underlying their pathology [<xref ref-type="bibr" rid="CR60">60</xref>]. Further, there is corroboration from the scientific study of the nervous system that cortical spreading depression and an epileptic focus may exacerbate each other [<xref ref-type="bibr" rid="CR61">61</xref>].</p><p id="Par39">In our subgroup analysis, the pooled prevalence of headaches among patients with epilepsy was considerably higher among females (63.0%) when compared to males (33.3%). Data from different epidemiologic studies reported that female manifests high prevalence of migraine [<xref ref-type="bibr" rid="CR62">62</xref>]. The same study also showed that female experiences more frequent, longer-lasting and more intense attacks than male [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. Further, scientific evidence has shown that primary headaches such as migraines are associated with sex hormones [<xref ref-type="bibr" rid="CR61">61</xref>]. Finding from this study showed that sex hormones in females affect cells around the trigeminal nerve as well as connected blood vessels in the head. The estrogens, which are hormones that are responsible for reproductive and sexual development in females, at their highest levels in the females of childbearing age are particularly important for sensitizing these cells to migraine triggers [<xref ref-type="bibr" rid="CR63">63</xref>]. Furthermore, a study included a total of 2082 study participants to investigate the effect of gender on the headache manifestations in migraine patients and reported that the headache intensity in males changed in an age-dependent manner and these variations were not seen in males [<xref ref-type="bibr" rid="CR64">64</xref>].</p><p id="Par40">The pooled prevalence of primary headaches among patients living with epilepsy did not differ in the subgroup analysis of developing and developed countries. For example, the pooled prevalence of primary headaches was 50.6% and 49.5% for developed and developing countries respectively. These may indicate the risk factors of headache among patients with epilepsy are common irrespective of the countries&#x02019; socio-economic status and suggesting some common biological factors are explaining the co-occurrence.</p></sec><sec id="Sec16"><title>Strength and limitations</title><p id="Par41">This systematic review and meta-analysis has the following strengths; we used a predefined search strategy and two independent reviewers conducted data extraction and quality appraisal to minimize reviewer bias, conducted sensitivity and subgroup analysis using types of headaches, the countries the study based and the gender of the participants as a moderator. Nevertheless, this systematic review has the following limitations. We got a small number of articles in the subgroup analysis which could decrease the accuracy of the estimate. We did not analyze the data on children due to lack of sufficient literature. Furthermore, some studies included in the review did not use standardized and validated data measurement tools. These may overestimate the prevalence of headache in the studies that used a non-standardized data collection tool. Moreover, the review included studies published in the English language only. This may under- or over-estimate the pooled prevalence of headache among patients with epilepsy.</p></sec><sec id="Sec17"><title>Conclusion</title><p id="Par42">The pooled prevalence estimates of headache among patients with epilepsy was considerably high when compared to the general population. The pooled prevalence of Inter Ictal headache (IIH) and Postictal headache (PIH) were higher when compared to tension-type headache (TTH), migraine with aura and migraine without aura. The pooled prevalence of headache was similar for developed and developing countries. The pooled prevalence of headache among patients with epilepsy was considerably higher among females when compared to males. Screening and appropriate management of headaches among patients with epilepsy are warranted.</p></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec18"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="10194_2020_1074_MOESM1_ESM.docx"><caption><p><bold>Additional file 1.</bold> The quality of studies included in systematic review and meta-analysis.</p></caption></media></supplementary-material>
</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>HALT</term><def><p id="Par5">The Headache-Attributed Lost Time</p></def></def-item><def-item><term>HIT-6</term><def><p id="Par6">The six-item Headache Impact Test</p></def></def-item><def-item><term>ICHD-III</term><def><p id="Par7">The International Classification of Headache Disorders 3rd edition</p></def></def-item><def-item><term>IHS</term><def><p id="Par8">International Headache Society</p></def></def-item><def-item><term>IIH</term><def><p id="Par9">Inter Ictal headache</p></def></def-item><def-item><term>MA</term><def><p id="Par10">Migraine with aura</p></def></def-item><def-item><term>MOA</term><def><p id="Par11">Migraine without aura</p></def></def-item><def-item><term>MSQ</term><def><p id="Par12">Migraine Screening Questionnaire</p></def></def-item><def-item><term>PIH</term><def><p id="Par13">Post ictal headache</p></def></def-item><def-item><term>TTH</term><def><p id="Par14">Tension type headache</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s10194-020-1074-0.</p></sec><ack><title>Acknowledgements</title><p>No acknowledgements at this stage.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>BD performed the database search, data extraction, quality assessment, analysis, and write-up and drafted the manuscript. MA performed the database search, data extraction and write-up. AT was involved in database search and write-up. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>The authors declare that there is no funding.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>All data generated or analyzed data in study are included in this article.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par44">N/A.</p></notes><notes><title>Consent for publication</title><p id="Par45">N/A.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par46">The authors declare that there is no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Thakur</surname><given-names>KT</given-names></name><name><surname>Albanese</surname><given-names>E</given-names></name><name><surname>Giannakopoulos</surname><given-names>P</given-names></name><name><surname>Jette</surname><given-names>N</given-names></name><name><surname>Linde</surname><given-names>M</given-names></name><name><surname>Prince</surname><given-names>MJ</given-names></name><etal/></person-group><source>Neurological Disorders</source><year>2016</year></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organazation</collab></person-group><source>keys facts on epilepsy</source><year>2019</year></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falco-Walter</surname><given-names>J</given-names></name><name><surname>Scheffer</surname><given-names>I</given-names></name><name><surname>Fisher</surname><given-names>R</given-names></name></person-group><article-title>The new definition and classification of seizures and epilepsy</article-title><source>Epilepsy Res</source><year>2018</year><volume>139</volume><fpage>73</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.eplepsyres.2017.11.015</pub-id><pub-id pub-id-type="pmid">29197668</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>RS</given-names></name><name><surname>Acevedo</surname><given-names>C</given-names></name><name><surname>Arzimanoglou</surname><given-names>A</given-names></name><name><surname>Bogacz</surname><given-names>A</given-names></name><name><surname>Cross</surname><given-names>JH</given-names></name><name><surname>Elger</surname><given-names>CE</given-names></name><etal/></person-group><article-title>ILAE official report: a practical clinical definition of epilepsy</article-title><source>Epilepsia.</source><year>2014</year><volume>55</volume><issue>4</issue><fpage>475</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1111/epi.12550</pub-id><pub-id pub-id-type="pmid">24730690</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunes</surname><given-names>V</given-names></name><name><surname>Sawyer</surname><given-names>L</given-names></name><name><surname>Neilson</surname><given-names>J</given-names></name><name><surname>Sarri</surname><given-names>G</given-names></name><name><surname>Cross</surname><given-names>J</given-names></name></person-group><article-title>Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance</article-title><source>BMJ.</source><year>2012</year><volume>344</volume><fpage>e281</fpage><pub-id pub-id-type="doi">10.1136/bmj.e281</pub-id><pub-id pub-id-type="pmid">22282528</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Trevick</surname><given-names>S</given-names></name></person-group><article-title>The epidemiology of global epilepsy</article-title><source>Neurol Clin</source><year>2016</year><volume>34</volume><fpage>837</fpage><lpage>847</lpage><pub-id pub-id-type="doi">10.1016/j.ncl.2016.06.015</pub-id><pub-id pub-id-type="pmid">27719996</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Boer</surname><given-names>H</given-names></name><name><surname>Mula</surname><given-names>M</given-names></name><name><surname>Sander</surname><given-names>J</given-names></name></person-group><article-title>The global burden and stigma of epilepsy</article-title><source>Epilepsy Behav</source><year>2008</year><volume>12</volume><fpage>540</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1016/j.yebeh.2007.12.019</pub-id><pub-id pub-id-type="pmid">18280210</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiest</surname><given-names>KM</given-names></name><name><surname>Sauro</surname><given-names>KM</given-names></name><name><surname>Wiebe</surname><given-names>S</given-names></name><name><surname>Patten</surname><given-names>SB</given-names></name><name><surname>Kwon</surname><given-names>CS</given-names></name><name><surname>Dykeman</surname><given-names>J</given-names></name><name><surname>Jett&#x000e9;</surname><given-names>N</given-names></name></person-group><article-title>Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies</article-title><source>Neurol</source><year>2017</year><volume>88</volume><issue>3</issue><fpage>296</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000003509</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petitmengin</surname><given-names>C</given-names></name></person-group><article-title>Describing One&#x02019;s subjective experience in the second person: an interview method for the science of consciousness</article-title><source>Phenomenol Cogn Sci</source><year>2006</year><volume>5</volume><fpage>229</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1007/s11097-006-9022-2</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borsook</surname><given-names>D</given-names></name><name><surname>Dodick</surname><given-names>DW</given-names></name></person-group><article-title>Taking the headache out of migraine</article-title><source>Neurology Clinical practice</source><year>2015</year><volume>5</volume><issue>4</issue><fpage>317</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1212/CPJ.0000000000000171</pub-id><pub-id pub-id-type="pmid">26335578</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Headache disorders Fact sheet N&#x000b0;277". October 2012<italic>.</italic> Archived from the original on 16 February 2016. Retrieved 15 February 2016.<ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Headache">https://en.wikipedia.org/wiki/Headache</ext-link></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Clinch C (2011) Chapter 28. Evaluation &#x00026; Management of headache - CURRENT Diagnosis &#x00026; Treatment in family medicine. In: South-Paul JE, Matheny SC, Lewis EL (eds) Lange Current Series, Third edn. McGraw-Hill. isbn:<ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Special:BookSources/9780071624367">9780071624367</ext-link></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Detsky ME<italic>,</italic> McDonald DR<italic>,</italic> Baerlocher MO<italic>,</italic> Tomlinson GA<italic>,</italic> McCrory DC<italic>,</italic> Booth CM <italic>(</italic>September 2006<italic>). "</italic>Does this patient with headache have a migraine or need neuroimaging?<italic>&#x0201d;</italic> JAMA. 296 <italic>(</italic>10<italic>):</italic> 1274<italic>&#x02013;</italic>1283<italic>.</italic> doi:10.1001/jama.296.10.1274.%20PMID%2016968852</mixed-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellosta-Diago</surname><given-names>E</given-names></name><name><surname>Velazquez-Benito</surname><given-names>A</given-names></name><name><surname>Viloria-Alebesque</surname><given-names>A</given-names></name><name><surname>Iniguez-Martinez</surname><given-names>C</given-names></name><name><surname>Santos-Lasaosa</surname><given-names>S</given-names></name></person-group><article-title>A study of sexual function in migraine and cluster headache</article-title><source>Rev Neurol</source><year>2016</year><volume>62</volume><issue>11</issue><fpage>487</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">27222082</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Ding</surname><given-names>Z</given-names></name><name><surname>Lian</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><etal/></person-group><article-title>Prevalence and Risk Factors of White Matter Lesions in Tibetan Patients Without Acute Stroke</article-title><source>Stroke</source><year>2019</year><volume>51</volume><issue>1</issue><fpage>149</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.119.027115</pub-id><pub-id pub-id-type="pmid">31679502</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinard</surname><given-names>KI</given-names></name><name><surname>Smith</surname><given-names>AG</given-names></name><name><surname>Singleton</surname><given-names>JR</given-names></name><name><surname>Lessard</surname><given-names>MK</given-names></name><name><surname>Katz</surname><given-names>BJ</given-names></name><name><surname>Warner</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Chronic migraine is associated with reduced corneal nerve fiber density and symptoms of dry eye</article-title><source>Headache.</source><year>2015</year><volume>55</volume><issue>4</issue><fpage>543</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1111/head.12547</pub-id><pub-id pub-id-type="pmid">25828778</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prontera</surname><given-names>P</given-names></name><name><surname>Sarchielli</surname><given-names>P</given-names></name><name><surname>Caproni</surname><given-names>S</given-names></name><name><surname>Bedetti</surname><given-names>C</given-names></name><name><surname>Cupini</surname><given-names>LM</given-names></name><name><surname>Calabresi</surname><given-names>P</given-names></name><etal/></person-group><article-title>Epilepsy in hemiplegic migraine: genetic mutations and clinical implications</article-title><source>Cephalalgia</source><year>2018</year><volume>38</volume><issue>2</issue><fpage>361</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1177/0333102416686347</pub-id><pub-id pub-id-type="pmid">28058944</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DW</given-names></name><name><surname>Lee</surname><given-names>SK</given-names></name></person-group><article-title>Headache and epilepsy</article-title><source>J Epilepsy Res</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>7</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.14581/jer.17002</pub-id><pub-id pub-id-type="pmid">28775949</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutherland</surname><given-names>HG</given-names></name><name><surname>Albury</surname><given-names>CL</given-names></name><name><surname>Griffiths</surname><given-names>LR</given-names></name></person-group><article-title>Advances in genetics of migraine</article-title><source>J Headache Pain</source><year>2019</year><volume>20</volume><fpage>72</fpage><pub-id pub-id-type="doi">10.1186/s10194-019-1017-9</pub-id><pub-id pub-id-type="pmid">31226929</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belcastro</surname><given-names>V</given-names></name><name><surname>Striano</surname><given-names>P</given-names></name><name><surname>Parisi</surname><given-names>P</given-names></name></person-group><article-title>&#x0201c;Ictal epileptic headache&#x0201d;: beyond the epidemiological evidence</article-title><source>Epilepsy Behav</source><year>2012</year><volume>25</volume><fpage>9</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.yebeh.2012.07.002</pub-id><pub-id pub-id-type="pmid">22980074</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Dedei Daryan M, Guveli BT (2018) Prevalence and clinical characteristics of headache in juvenile myoclonic epilepsy: experience from a tertiary epilepsy center. 39(3):519&#x02013;525</mixed-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingston</surname><given-names>WS</given-names></name><name><surname>Schwedt</surname><given-names>TJ</given-names></name></person-group><article-title>The relationship between headaches with epileptic and non-epileptic seizures: a narrative review</article-title><source>Curr Pain Headache Rep</source><year>2017</year><volume>21</volume><issue>3</issue><fpage>17</fpage><pub-id pub-id-type="doi">10.1007/s11916-017-0617-9</pub-id><pub-id pub-id-type="pmid">28271336</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nesterovsky</surname><given-names>YE</given-names></name><name><surname>Zavadenko</surname><given-names>NN</given-names></name></person-group><article-title>Comorbidity of migraine and epilepsy in childhood</article-title><source>Zh Nevrol Psikhiatr Im S S Korsakova</source><year>2018</year><volume>118</volume><issue>4</issue><fpage>100</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.17116/jnevro201811841100-106</pub-id><pub-id pub-id-type="pmid">29863702</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutlu</surname><given-names>A</given-names></name></person-group><article-title>Association between epilepsy and headache</article-title><source>Neurol Sci</source><year>2018</year><volume>39</volume><issue>12</issue><fpage>2129</fpage><lpage>2134</lpage><pub-id pub-id-type="doi">10.1007/s10072-018-3558-0</pub-id><pub-id pub-id-type="pmid">30209697</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>XQ</given-names></name><name><surname>Lang</surname><given-names>SY</given-names></name><name><surname>He</surname><given-names>MW</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>F</given-names></name><name><surname>Dai</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>SY</given-names></name></person-group><article-title>High prevalence of headaches in patients with epilepsy</article-title><source>J Headache Pain</source><year>2014</year><volume>15</volume><issue>1</issue><fpage>70</fpage><pub-id pub-id-type="doi">10.1186/1129-2377-15-70</pub-id><pub-id pub-id-type="pmid">25366245</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>F</given-names></name><name><surname>Honma</surname><given-names>H</given-names></name><name><surname>Takeda</surname><given-names>Y</given-names></name><name><surname>Kobayashi</surname><given-names>R</given-names></name><name><surname>Miyamoto</surname><given-names>T</given-names></name><etal/></person-group><article-title>Clinical factors associated with post-ictal headache in patients with epilepsy</article-title><source>Acta Neurol Scand</source><year>2000</year><volume>102</volume><issue>2</issue><fpage>129</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1034/j.1600-0404.2000.102002129.x</pub-id><pub-id pub-id-type="pmid">10949531</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keezer</surname><given-names>MR</given-names></name><name><surname>Sisodiya</surname><given-names>SM</given-names></name><name><surname>Sander</surname><given-names>JW</given-names></name></person-group><article-title>Comorbidities of epilepsy: current concepts and future perspectives</article-title><source>Lancet Neurol</source><year>2016</year><volume>15</volume><issue>1</issue><fpage>106</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(15)00225-2</pub-id><pub-id pub-id-type="pmid">26549780</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Reviews UoYCf (2009) Dissemination. Systematic reviews: CRD's guidance for undertaking reviews in health care. University of York, Centre for Reviews &#x00026; Dissemination</mixed-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stang</surname><given-names>A</given-names></name></person-group><article-title>Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses</article-title><source>Eur J Epidemiol</source><year>2010</year><volume>25</volume><issue>9</issue><fpage>6035</fpage><pub-id pub-id-type="doi">10.1007/s10654-010-9491-z</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modesti</surname><given-names>PA</given-names></name><name><surname>Reboldi</surname><given-names>G</given-names></name><name><surname>Cappuccio</surname><given-names>FP</given-names></name><name><surname>Agyemang</surname><given-names>C</given-names></name><name><surname>Remuzzi</surname><given-names>G</given-names></name><name><surname>Rapi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><issue>1</issue><fpage>e0147601</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0147601</pub-id><pub-id pub-id-type="pmid">26808317</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borenstein</surname><given-names>M</given-names></name><name><surname>Hedges</surname><given-names>LV</given-names></name><name><surname>Higgins</surname><given-names>J</given-names></name><name><surname>Rothstein</surname><given-names>HR</given-names></name></person-group><article-title>A basic introduction to fixed-effect and random-effects models for meta-analysis</article-title><source>Res Synth Methods</source><year>2010</year><volume>1</volume><issue>2</issue><fpage>97</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1002/jrsm.12</pub-id><pub-id pub-id-type="pmid">26061376</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>JP</given-names></name><name><surname>Thompson</surname><given-names>SG</given-names></name><name><surname>Deeks</surname><given-names>JJ</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name></person-group><article-title>Measuring inconsistency in meta-analyses</article-title><source>BMJ</source><year>2003</year><volume>327</volume><issue>7414</issue><fpage>557</fpage><pub-id pub-id-type="doi">10.1136/bmj.327.7414.557</pub-id><pub-id pub-id-type="pmid">12958120</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterne</surname><given-names>JAC</given-names></name><name><surname>Gavaghan</surname><given-names>D</given-names></name><name><surname>Egger</surname><given-names>M</given-names></name></person-group><article-title>Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature</article-title><source>J Clin Epidemiol</source><year>2000</year><volume>53</volume><issue>11</issue><fpage>1119</fpage><lpage>1129</lpage><pub-id pub-id-type="doi">10.1016/S0895-4356(00)00242-0</pub-id><pub-id pub-id-type="pmid">11106885</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>EK</given-names></name><name><surname>Mehta</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Nakamoto</surname><given-names>B</given-names></name><name><surname>McMurtray</surname><given-names>AM</given-names></name></person-group><article-title>Headaches more common among epilepsy sufferers with Neurocysticercosis than other structural brain lesions</article-title><source>Hawai'i J Med Public Health</source><year>2017</year><volume>76</volume><issue>6</issue><fpage>152</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">28607832</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singla</surname><given-names>M</given-names></name><name><surname>Mayyer</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>G</given-names></name><name><surname>Sidhu</surname><given-names>J</given-names></name><name><surname>Aggarwal</surname><given-names>S</given-names></name></person-group><article-title>To study the prevalence of headache in patients with epilepsy</article-title><source>J Neurol Sci</source><year>2017</year><volume>381</volume><fpage>689</fpage><pub-id pub-id-type="doi">10.1016/j.jns.2017.08.1938</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jabbehdari</surname><given-names>S</given-names></name><name><surname>Hesami</surname><given-names>O</given-names></name><name><surname>Chavoshnejad</surname><given-names>M</given-names></name></person-group><article-title>Prevalence of migraine headache in epileptic patients</article-title><source>Acta Medica Iranica</source><year>2015</year><volume>53</volume><issue>6</issue><fpage>373</fpage><lpage>375</lpage><pub-id pub-id-type="pmid">26069176</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nahid</surname><given-names>A</given-names></name><name><surname>Hakimeh</surname><given-names>J</given-names></name></person-group><article-title>the prevalence of migraine and tension type headaches among epileptic patients</article-title><source>Caspian J Neurol Sci</source><year>2015</year><volume>1</volume><issue>3</issue><fpage>41</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.18869/acadpub.cjns.1.3.41</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fattahzadeh-Ardalani</surname><given-names>G</given-names></name><name><surname>Ahari</surname><given-names>SS</given-names></name><name><surname>Amani</surname><given-names>F</given-names></name><name><surname>Moghaddamnia</surname><given-names>V</given-names></name></person-group><article-title>prevalence of migraine and tension headaches and related factors, 2014</article-title><source>Int J Res Med Sci</source><year>2017</year><volume>5</volume><issue>5</issue><fpage>2016</fpage><lpage>2020</lpage><pub-id pub-id-type="doi">10.18203/2320-6012.ijrms20171835</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mainieri</surname><given-names>G</given-names></name><name><surname>Cevoli</surname><given-names>S</given-names></name><name><surname>Giannini</surname><given-names>G</given-names></name><name><surname>Zummo</surname><given-names>L</given-names></name><name><surname>Leta</surname><given-names>C</given-names></name><name><surname>Broli</surname><given-names>M</given-names></name><etal/></person-group><article-title>Headache in epilepsy: prevalence and clinical features</article-title><source>J Headache Pain.</source><year>2015</year><volume>16</volume><fpage>556</fpage><pub-id pub-id-type="doi">10.1186/s10194-015-0556-y</pub-id><pub-id pub-id-type="pmid">26245188</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Qiu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Relationship between right-to-left shunt and migraine in patients with epilepsy: a single-Centre, cross-sectional study in China</article-title><source>BMJ Open</source><year>2018</year><volume>8</volume><fpage>e024144</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2018-024144</pub-id><pub-id pub-id-type="pmid">30297353</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000d6;zer</surname><given-names>G</given-names></name><name><surname>&#x000dc;nal</surname><given-names>Y</given-names></name><name><surname>Kutlu</surname><given-names>G</given-names></name><name><surname>G&#x000f6;mceli</surname><given-names>Y</given-names></name><name><surname>Inan</surname><given-names>L</given-names></name></person-group><article-title>Prevalence of Interictal headache in patients with epilepsy</article-title><source>Epilepsi</source><year>2018</year><volume>24</volume><issue>2</issue><fpage>51</fpage><lpage>54</lpage></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mameniskiene</surname><given-names>R</given-names></name><name><surname>Karmonaite</surname><given-names>I</given-names></name><name><surname>Zagorskis</surname><given-names>R</given-names></name></person-group><article-title>The burden of headache in people with epilepsy</article-title><source>Seizure.</source><year>2016</year><volume>41</volume><fpage>120</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1016/j.seizure.2016.07.018</pub-id><pub-id pub-id-type="pmid">27543963</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vujisi</surname><given-names>S</given-names></name><name><surname>Radulovi</surname><given-names>L</given-names></name><name><surname>Vodopi</surname><given-names>S</given-names></name></person-group><article-title>comorbidity of epilepsy and migraines epidemiological and clinical aspects</article-title><source>SANAMED</source><year>2012</year><volume>7</volume><issue>2</issue><fpage>79</fpage><lpage>84</lpage></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rashid</surname><given-names>S</given-names></name><name><surname>Alam</surname><given-names>MM</given-names></name></person-group><article-title>Headache Associated with Epileptic Seizures: Epidemiology and Clinical Characteristics</article-title><source>IOSR J Dental Med Sci</source><year>2018</year><volume>17</volume><issue>9</issue><fpage>17</fpage><lpage>24</lpage></element-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">Yosria Abd Al Hameed Altaweel, Amal Salah El-Din Mohamed El-Motayam, Khaled Aly El-Sharkawy, and Mohammed Hanafy Aly Ghonemy, &#x0201c;Prevalence of Comorbidity of Migraine and Atopic Diseases among Patients with Idiopathic Epilepsy in Zagazig University Hospitals, Int J Clin Exp Neurol, 5, no. 1 (2017): 18&#x02013;27. doi: 10.12691/ijcen-5-1-5</mixed-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayed</surname><given-names>M</given-names></name><name><surname>Ibrahim</surname><given-names>H</given-names></name><name><surname>Bekhit</surname><given-names>A</given-names></name><name><surname>Thabit</surname><given-names>M</given-names></name><name><surname>Abdelmomen</surname><given-names>M</given-names></name></person-group><article-title>Clinical characteristics of headache in Egyptian patients with idiopathic epilepsy</article-title><source>J Behav Brain Sci</source><year>2019</year><volume>9</volume><fpage>144</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.4236/jbbs.2019.93012</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>I-C</given-names></name><name><surname>Chen</surname><given-names>Y-J</given-names></name></person-group><article-title>Incidence and characteristics of headaches in a retrospective cohort of Taiwanese children with focal epilepsy</article-title><source>Neuropsychiatry (London)</source><year>2018</year><volume>8</volume><issue>2</issue><fpage>727</fpage><lpage>732</lpage></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organazation (WHO)</collab></person-group><source>Headache disorders</source><year>2016</year></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Hock</surname><given-names>D</given-names></name><name><surname>Yue</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Prevalence of primary headache disorders in a population aged 60 years and older in a rural area of northern China</article-title><source>J Headache Pain</source><year>2016</year><volume>17</volume><issue>1</issue><fpage>83</fpage><pub-id pub-id-type="doi">10.1186/s10194-016-0672-3</pub-id><pub-id pub-id-type="pmid">27619363</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">Al-Hashel JY, Ahmed SF, Alroughani R (2019) Prevalence and Burden of Primary Headache Disorders in Kuwaiti Children and Adolescents: A Community Based Study. Front Neurol 10(793)</mixed-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almesned</surname><given-names>IS</given-names></name><name><surname>Alqahtani</surname><given-names>NG</given-names></name><name><surname>Alarifi</surname><given-names>JA</given-names></name><name><surname>Alsaawy</surname><given-names>TN</given-names></name><name><surname>Agha</surname><given-names>S</given-names></name><name><surname>Alhumaid</surname><given-names>MA</given-names></name></person-group><article-title>Prevalence of primary headache among medical students at king Saud bin Abdulaziz University for health sciences, Riyadh, Saudi Arabia</article-title><source>J Fam Med Prim Care</source><year>2018</year><volume>7</volume><issue>6</issue><fpage>1193</fpage><lpage>1196</lpage><pub-id pub-id-type="doi">10.4103/jfmpc.jfmpc_240_18</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirsattari</surname><given-names>SM</given-names></name><name><surname>Power</surname><given-names>C</given-names></name><name><surname>Nath</surname><given-names>A</given-names></name></person-group><article-title>Primary headaches in HIV-infected patients</article-title><source>Headache.</source><year>1999</year><volume>39</volume><issue>1</issue><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.1999.3901003.x</pub-id><pub-id pub-id-type="pmid">15613188</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunklaus</surname><given-names>A</given-names></name><name><surname>Ellis</surname><given-names>R</given-names></name><name><surname>Reavey</surname><given-names>E</given-names></name><name><surname>Forbes</surname><given-names>GH</given-names></name><name><surname>Zuberi</surname><given-names>SM</given-names></name></person-group><article-title>Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome</article-title><source>Brain</source><year>2012</year><volume>135</volume><fpage>2329</fpage><lpage>2336</lpage><pub-id pub-id-type="doi">10.1093/brain/aws151</pub-id><pub-id pub-id-type="pmid">22719002</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ligthart</surname><given-names>L</given-names></name><name><surname>Boomsma</surname><given-names>DI</given-names></name></person-group><article-title>causes of comorbidity: pleiotropy or causality? Shared genetic and environmental influences on migraine and neuroticism</article-title><source>Twin Res Hum Genet</source><year>2012</year><volume>15</volume><fpage>158</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1375/twin.15.2.158</pub-id><pub-id pub-id-type="pmid">22856357</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winawer</surname><given-names>MR</given-names></name><name><surname>Connors</surname><given-names>R</given-names></name></person-group><article-title>Evidence for a shared genetic susceptibility to migraine and epilepsy</article-title><source>Epilepsia.</source><year>2013</year><volume>54</volume><issue>2</issue><fpage>288</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1111/epi.12072</pub-id><pub-id pub-id-type="pmid">23294289</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="other">Rogawski MA Migraine and Epilepsy&#x02014;Shared Mechanisms within the Family of Episodic Disorders, asper's Basic Mechanisms of the Epilepsies [Internet], 4th edn <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK98193/">https://www.ncbi.nlm.nih.gov/books/NBK98193/</ext-link></mixed-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>TJ</given-names></name><name><surname>Stovner</surname><given-names>LJ</given-names></name><name><surname>Birbeck</surname><given-names>GL</given-names></name></person-group><article-title>Migraine: the seventh disabler</article-title><source>J Headache Pain</source><year>2013</year><volume>14</volume><issue>1</issue><fpage>1</fpage><pub-id pub-id-type="doi">10.1186/1129-2377-14-1</pub-id><pub-id pub-id-type="pmid">23566305</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natoli</surname><given-names>JL</given-names></name><name><surname>Manack</surname><given-names>A</given-names></name><name><surname>Dean</surname><given-names>B</given-names></name><name><surname>Butler</surname><given-names>Q</given-names></name><name><surname>Turkel</surname><given-names>CC</given-names></name><name><surname>Stovner</surname><given-names>L</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name></person-group><article-title>Global prevalence of chronic migraine: A systematic review</article-title><source>Cephalalgia</source><year>2009</year><volume>30</volume><issue>5</issue><fpage>599</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2009.01941.x</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanmolkot</surname><given-names>KR</given-names></name><name><surname>Kors</surname><given-names>EE</given-names></name><name><surname>Hottenga</surname><given-names>JJ</given-names></name><name><surname>Terwindt</surname><given-names>GM</given-names></name><name><surname>Haan</surname><given-names>J</given-names></name><name><surname>Hoefnagels</surname><given-names>WA</given-names></name><name><surname>Black</surname><given-names>DF</given-names></name><name><surname>Sandkuijl</surname><given-names>LA</given-names></name><name><surname>Frants</surname><given-names>RR</given-names></name><name><surname>Ferrari</surname><given-names>MD</given-names></name><name><surname>van den Maagdenberg</surname><given-names>AM</given-names></name></person-group><article-title>Novel mutations in the Na+, K&#x02009;+&#x02009;&#x02212;ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions</article-title><source>Ann Neurol</source><year>2003</year><volume>54</volume><fpage>360</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1002/ana.10674</pub-id><pub-id pub-id-type="pmid">12953268</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eikermann-Haerter</surname><given-names>K</given-names></name><name><surname>Negro</surname><given-names>A</given-names></name><name><surname>Ayata</surname><given-names>C</given-names></name></person-group><article-title>Spreading depression and the clinical correlates of migraine</article-title><source>Rev Neurosci</source><year>2013</year><volume>24</volume><fpage>353</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1515/revneuro-2013-0005</pub-id><pub-id pub-id-type="pmid">23907418</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="other">Artero-Morales M, Gonz&#x000e1;lez-Rodr&#x000ed;guez S, Ferrer-Montiel A (2018) TRP Channels as Potential Targets for Sex-Related Differences in Migraine Pain. Front Mol Biosci 5(73)</mixed-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boardman</surname><given-names>HF</given-names></name><name><surname>Thomas</surname><given-names>E</given-names></name><name><surname>Croft</surname><given-names>PR</given-names></name><name><surname>Millson</surname><given-names>DS</given-names></name></person-group><article-title>Epidemiology of headache in an English district</article-title><source>Cephalalgia</source><year>2003</year><volume>23</volume><fpage>129</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1046/j.1468-2982.2003.00468.x</pub-id><pub-id pub-id-type="pmid">12603370</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolay</surname><given-names>H</given-names></name><name><surname>Ozge</surname><given-names>A</given-names></name><name><surname>Saginc</surname><given-names>P</given-names></name><name><surname>Orekici</surname><given-names>G</given-names></name><name><surname>Ulud&#x000fc;z</surname><given-names>D</given-names></name><name><surname>Yalin</surname><given-names>O</given-names></name><etal/></person-group><article-title>Gender influences headache characteristics with increasing age in migraine patients</article-title><source>Cephalalgia</source><year>2015</year><volume>35</volume><fpage>792</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1177/0333102414559735</pub-id><pub-id pub-id-type="pmid">25424708</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwan</surname><given-names>P</given-names></name><name><surname>Man</surname><given-names>CB</given-names></name><name><surname>Leung</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>E</given-names></name><name><surname>Wong</surname><given-names>KS</given-names></name></person-group><article-title>Headache in patients with epilepsy: a prospective incidence study</article-title><source>Epilepsia.</source><year>2008</year><volume>49</volume><issue>6</issue><fpage>1099</fpage><lpage>1102</lpage><pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01574.x</pub-id><pub-id pub-id-type="pmid">18363711</pub-id></element-citation></ref></ref-list></back></article>